David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
IMPORTANT: As of 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
TRANSIT ALERT: Major cuts to bus, subway, and rail may affect travel to and from our campuses. Read full update.
David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
Becker’s Hospital Review highlighted the Temple Heart and Vascular Institute’s recent achievement of completing its 500th pulmonary thromboendarterectomy and 500th balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension (CTEPH).
Read MoreSabrina Islam, MD, MPH, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University, shared with Everyday Health common dos and don’ts of statins, a class of medications that can lower levels of LDL (“bad”) cholesterol.
View Details